UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research

Wood, L; Cordts, I; Atalaia, A; Marini-Bettolo, C; Maddison, P; Phillips, M; Roberts, M; ... Lochmuller, H; + view all (2017) The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research. Journal of Neurology , 264 (5) pp. 979-988. 10.1007/s00415-017-8483-2. Green open access

[thumbnail of Orrell_017-8483-2.pdf]
Preview
Text
Orrell_017-8483-2.pdf - Published Version

Download (682kB) | Preview

Abstract

Myotonic dystrophy type 1 (DM1) is the most frequent muscular dystrophy worldwide with complex, multi-systemic, and progressively worsening symptoms. There is currently no treatment for this inherited disorder and research can be challenging due to the rarity and variability of the disease. The UK Myotonic Dystrophy Patient Registry is a patient self-enrolling online database collecting clinical and genetic information. For this cross-sectional “snapshot” analysis, 556 patients with a confirmed diagnosis of DM1 registered between May 2012 and July 2016 were included. An almost even distribution was seen between genders and a broad range of ages was present from 8 months to 78 years, with the largest proportion between 30 and 59 years. The two most frequent symptoms were fatigue and myotonia, reported by 79 and 78% of patients, respectively. The severity of myotonia correlated with the severity of fatigue as well as mobility impairment, and dysphagia occurred mostly in patients also reporting myotonia. Men reported significantly more frequent severe myotonia, whereas severe fatigue was more frequently reported by women. Cardiac abnormalities were diagnosed in 48% of patients and more than one-third of them needed a cardiac implant. Fifteen percent of patients used a non-invasive ventilation and cataracts were removed in 26% of patients, 65% of which before the age of 50 years. The registry’s primary aim was to facilitate and accelerate clinical research. However, these data also allow us to formulate questions for hypothesis-driven research that may lead to improvements in care and treatment.

Type: Article
Title: The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s00415-017-8483-2
Publisher version: http://doi.org/10.1007/s00415-017-8483-2
Language: English
Additional information: Copyright © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Myotonic dystrophy, Patient Registries, Clinical trials, Trial readiness
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/1555501
Downloads since deposit
74Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item